In a patient with severe back pain who can barely walk and no evidence of inflammatory spondylitis, should I prescribe diazepam and systemic steroids?

Do Not Prescribe Diazepam and Systemic Steroids for This Patient

Based on high-quality guideline evidence, you should NOT prescribe either diazepam or systemic steroids for severe back pain without inflammatory spondylitis. Both medications lack efficacy for this indication and carry significant risks.

Why Not Steroids?

Systemic corticosteroids do not work for low back pain. The 2017 American College of Physicians systematic review explicitly states that "systemic corticosteroids do not seem to be effective" for low back pain 1. This finding is reinforced by additional research concluding that systemic steroid administration "should definitively be banned" for back pain and sciatica due to lack of clinical evidence 2.

• No benefit has been demonstrated for pain relief or functional improvement
• The practice lacks any supporting evidence from clinical trials
• This applies to both acute and chronic low back pain

Why Not Diazepam (Benzodiazepines)?

Benzodiazepines are ineffective for back pain. The same 2017 ACP guideline found that benzodiazepines were specifically "ineffective for radiculopathy" 1. While the FDA label indicates diazepam can be used as an adjunct for skeletal muscle spasm 3, this is contradicted by the higher-quality systematic review evidence showing lack of efficacy.

Critical Safety Concerns with Diazepam:

The FDA label carries multiple black box warnings 3:

• Risk of abuse, misuse, and addiction leading to overdose or death
• Physical dependence develops with continued use
• Acute withdrawal reactions can be life-threatening (including seizures) if stopped abruptly
• Profound sedation that impairs function
• If you later need to prescribe opioids for severe pain, combining them with benzodiazepines dramatically increases risk of respiratory depression, coma, and death

What You Should Prescribe Instead

Based on the guideline evidence 1:

First-Line Options:

• NSAIDs - Most effective first-line choice with moderate evidence for short-term pain relief and functional improvement 1, 4
• Skeletal muscle relaxants (NOT benzodiazepines) - Effective for short-term pain relief in acute low back pain, though they cause sedation 1

Specific Recommendations:

1. Start with an NSAID at appropriate dosing
2. If muscle spasm is prominent, add a non-benzodiazepine skeletal muscle relaxant (e.g., methocarbamol, cyclobenzaprine)
3. Advise the patient to stay active within pain limits - bed rest is counterproductive 5
4. Reassure that 90% of acute episodes resolve within 6 weeks 5

Common Pitfall to Avoid:

Do not reach for benzodiazepines or steroids simply because the pain is severe. Severity of pain does not change the evidence - these medications still don't work and carry substantial risks. A recent 2023 trial comparing methocarbamol to diazepam found both reduced pain when combined with morphine, but diazepam caused significantly more drowsiness (29.4% vs 4.0%) 6, further supporting the use of non-benzodiazepine muscle relaxants when needed.

Red Flags Requiring Different Management:

Ensure you've ruled out:

• Cauda equina syndrome (saddle anesthesia, bowel/bladder dysfunction)
• Severe or progressive neurologic deficits
• Infection, cancer, or fracture as underlying causes

If any red flags are present, imaging and specialist referral are indicated rather than empiric medication management 5.